Aurora Cannabis Inc (ACB) Q3 2025 Earnings Call Highlights: Record Growth in Medical Cannabis ...
Aurora Cannabis Inc (ACB) reports a robust quarter with significant increases in global medical cannabis revenue and a positive shift in net income.
Aurora Cannabis turns bullish after earnings [Video]
Basic bullish pattern shows that Aurora Cannabis formed a bullish setup with an impulsive five-wave rally, followed by an ABC correction, which can send the price higher by Elliott wave theory. For more analysis like this,
Aurora Cannabis boosts Canadian peers after Q3 beat
Aurora Cannabis (ACB) stock jumps and its Canadian rivals also rise as the company reports better-than-expected revenue for Q3 fiscal 2025. Read more here.
Aurora Cannabis Third Quarter 2025 Earnings: EPS: CA$0.57 (vs CA$0.51 loss in 3Q 2024)
CA$31.6m (up from CA$24.2m loss in 3Q 2024). Profit margin: 36% (up from net loss in 3Q 2024). EPS: CA$0.57 (up from CA$0.51 loss in 3Q 2024). Looking ahead, revenue is forecast to grow 11% p.a. on average during the next 3 years,
Aurora Cannabis (ACB) Q3 2025 Earnings Call Transcript
Operator Greetings, and welcome to the Aurora Cannabis Inc. third quarter 2025 results conference call. [Operator instructions] This conference call is being recorded today, Wednesday, February 5, 2025.
Roth MKM Remains a Hold on Aurora Cannabis (ACB)
In a report released today, Bill Kirk from Roth MKM reiterated a Hold rating on Aurora Cannabis (ACB – Research Report), with a price target of
Aurora Cannabis Shares Higher on 3Q Revenue Beat, Swing to Profit
Aurora Cannabis shares jumped Wednesday morning after its medical-cannabis segment supported a 37% increase in revenue in the company's fiscal third quarter. Shares traded 42% higher at 7.49 Canadian dollars ($5.
Aurora Cannabis shares surge on strong Q3 results
Shares of Aurora Cannabis Inc. (NASDAQ: NASDAQ:ACB) (TSX: ACB) soared 40% following the announcement of its fiscal 2025 third-quarter results. The Edmonton-based company reported a significant increase in revenue and profitability,
TLRY, CGC: Cannabis Stocks Rally on Aurora’s Strong Earnings
Cannabis stocks Tilray (TLRY) and Canopy Growth (CGC) rallied 7% and 22.2%, respectively, on Wednesday. One of the key drivers of this upside
(PR) Aurora Cannabis Announces Fiscal 2025 Third Quarter Results
Reports Total Net Revenue1 of $88.2 Million, up 37% YoY, Including Record Net Revenue1 of $68.1 Million in Global Medical Cannabis, up 51% YoY -- Generates Record Net Income of $31.2 Million, up 282% YoY,
Aurora Cannabis: Remarkable Recovery
Aurora Cannabis has shifted focus to the medical cannabis market, achieving higher gross margins. Read why I upgrade ACB ...
Money Morning22h
Aurora Cannabis Skyrockets but Don’t Fight its Bearish Trend
Aurora Cannabis’ short interest ratio sits at 5.2. This tells us that short interest on the stock is relatively high. It also ...
Aurora Cannabis price target raised to C$12.50 from C$10 at Canaccord
Canaccord raised the firm’s price target on Aurora Cannabis (ACB) to C$12.50 from C$10 and keeps a Buy rating on the shares.Maximize Your ...
Cannabis stocks climb on RFK Jr. committee vote and Senate banking hearing
Senate actions provided fuel for cannabis stocks to rise on Wednesday, with one committee looking into easing regulations for banks to handle transactions related to legal cannabis businesses, while ...
Why Aurora Cannabis Stock Is Skyrocketing Wednesday: What About Canopy, Tilray, Cronos?
Aurora Cannabis (NASDAQ: ACB) surged 45% after reporting record earnings, boosting CGC, TLRY, and CRON stocks.
Aurora Cannabis price target raised to C$10 from C$9 at TD Securities
TD Securities raised the firm’s price target on Aurora Cannabis (ACB) to C$10 from C$9 and keeps a Buy rating on the shares.Maximize Your ...
Aurora Cannabis Launches Its First Germany-Made Medical Cannabis Brand
Aurora announced this week the launch of its brand, IndiMed, which manufactures medical cannabis products at Aurora’s leading ...